Display options
Share it on

Cardiol Res Pract. 2009;2009:194528. doi: 10.4061/2009/194528. Epub 2009 Dec 22.

Depression following thrombotic cardiovascular events in elderly medicare beneficiaries: risk of morbidity and mortality.

Cardiology research and practice

Christopher M Blanchette, Linda Simoni-Wastila, Fadia T Shaya, Denise Orwig, Jason Noel, Bruce Stuart

Affiliations

  1. Division of Clinical and Outcomes Research, Lovelace Respiratory Research Institute, Albuquerque, NM 87108, USA.

PMID: 20069046 PMCID: PMC2800999 DOI: 10.4061/2009/194528

Abstract

Purpose. Depression and antidepressant use may independently increase the risk of acute myocardial infarction and mortality in adults. However, no studies have looked at the effect of depression on a broader thrombotic event outcome, assessed antidepressant use, or evaluated elderly adults. Methods. A cohort of 7,051 community-dwelling elderly beneficiaries who experienced a thrombotic cardiovascular event (TCE) were pooled from the 1997 to 2002 Medicare Current Beneficiary Survey and followed for 12 months. Baseline characteristics, antidepressant utilization, and death were ascertained from the survey, while indexed TCE, recurrent TCE, and depression (within 6 months of indexed TCE) were taken from ICD-9 codes on Medicare claims. Time to death and first recurrent TCE were assessed using descriptive and multivariate statistics. Results. Of the elders with a depression claim, 71.6% had a recurrent TCE and 4.7% died within 12 months of their indexed TCE, compared to 67.6% and 3.9% of those elders without a depression claim. Of the antidepressant users, 72.6% experienced a recurrent TCE and 3.9% died, compared to 73.7% and 4.6% in the subset of selective serotonin reuptake inhibitor (SSRI) users. Depression was associated with a shorter time to death (P = .008) in the unadjusted analysis. However, all adjusted comparisons revealed no effect by depression, antidepressant use, or SSRI use. Conclusions. Depression was not associated with time to death or recurrent TCEs in this study. Antidepressant use, including measures of any antidepressant use and SSRI use, was not associated with shorter time to death or recurrent TCE.

References

  1. Arch Intern Med. 2005 Jan 24;165(2):181-6 - PubMed
  2. Psychosom Med. 2000 Mar-Apr;62(2):212-9 - PubMed
  3. Drug Saf. 2004;27(14):1157-65 - PubMed
  4. Br Med J (Clin Res Ed). 1988 Jan 30;296(6618):320-31 - PubMed
  5. Health Aff (Millwood). 2005 Jan-Jun;Suppl Web Exclusives:W5-167-W5-179 - PubMed
  6. JAMA. 1997 May 28;277(20):1618-23 - PubMed
  7. Br J Clin Pharmacol. 2001 Aug;52(2):179-84 - PubMed
  8. Circulation. 2000 Apr 25;101(16):1919-24 - PubMed
  9. Am J Med. 2000 Jan;108(1):2-8 - PubMed
  10. Circulation. 1996 Jun 1;93(11):1976-80 - PubMed
  11. JAMA. 1993 Oct 20;270(15):1819-25 - PubMed
  12. JAMA. 1992 Jan 22-29;267(4):515-9 - PubMed
  13. Eur Heart J. 1991 Sep;12(9):959-64 - PubMed
  14. Am J Cardiol. 2001 Aug 15;88(4):337-41 - PubMed
  15. QJM. 2000 Nov;93(11):739-44 - PubMed
  16. Circulation. 2001 Oct 16;104(16):1894-8 - PubMed
  17. J Cardiovasc Risk. 2002 Jun;9(3):153-60 - PubMed
  18. Psychol Med. 1997 Nov;27(6):1397-409 - PubMed
  19. Circulation. 2003 Aug 26;108(8):939-44 - PubMed
  20. CMAJ. 2003 Mar 4;168(5):547-52 - PubMed
  21. Am J Psychiatry. 1988 Aug;145(8):976-81 - PubMed
  22. J Intern Med. 2000 Jun;247(6):629-39 - PubMed
  23. Heart. 2005 Apr;91(4):465-71 - PubMed
  24. J Clin Psychiatry. 2006 Jun;67(6):972-82 - PubMed
  25. J Psychosom Res. 2000 Oct;49(4):229-38 - PubMed
  26. Circulation. 2003 Jul 8;108(1):32-6 - PubMed
  27. Int J Geriatr Psychiatry. 2000 May;15(5):419-33 - PubMed
  28. Can J Psychiatry. 2004 Mar;49(3 Suppl 1):10S-16S - PubMed
  29. Milbank Q. 2002;80(2):347-79 - PubMed
  30. Cardiovasc Res. 1999 Jan;41(1):267-74 - PubMed
  31. Circulation. 1995 Feb 15;91(4):999-1005 - PubMed
  32. Gen Hosp Psychiatry. 2003 May-Jun;25(3):178-84 - PubMed

Publication Types

Grant support